US lawsuit puts generic drug imports from India under scanner

US lawsuit puts generic drug imports from India under scanner WASHINGTON: A US class action lawsuit accusing India’s Ranbaxy of large-scale deception on its generic drug applications puts a question mark on drug imports from India, the largest supplier of generic drugs to the US. The problem of lack of compliance with US Food and Drug Administration (FDA) guidance and ... Read More »

Story of a girl and apple..

Story of a girl and apple A lovely little girl was holding two apples with both hands. Her mum came in and softly asked her little daughter with a smile: my sweetie, could you give your mum one of your two apples? The girl looked up at her mum for some seconds, then she suddenly took a quick bite on ... Read More »

US pharma sector welcomes India’s intellectual property policy

US pharma sector welcomes India’s intellectual property policy The US pharma sector has welcomed India’s recent moves on intellectual property, including bringing out a draft policy and sustained engagement, while regretting the consistent barriers posed by the country’s pharma sector to US companies. Acknowledging the “measured and cautious approach” of India in responding to recent requests for compulsory licenses and ... Read More »

Glenmark Pharma receives US FDA approval for calcipotriene cream

Glenmark Pharma receives US FDA approval for calcipotriene cream Glenmark Pharmaceuticals Inc., USA (Glenmark), a subsidiary of Glenmark Pharmaceuticals, Mumbai, has received tentative approval from United States Food & Drug Administration (FDA) for calcipotriene cream, 0.005 per cent, the therapeutic equivalent of Dovonex topical cream, 0.005 per cent of Leo Pharma A/S. Glenmark will market this product upon receiving final ... Read More »

FDA grants Priority Review for potential new indication for Brilinta

FDA grants Priority Review for potential new indication for Brilinta AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA) and granted Priority Review for BRILINTA® (ticagrelor) tablets for patients with a history of heart attack. The sNDA is based on the results of the PEGASUS-TIMI 54 study, a large-scale outcomes ... Read More »

Invest in pharma sector: Dipan Mehta

Invest in pharma sector: Dipan Mehta Dipan Mehta, Member at BSE & NSE is overweight in pharma sector and feels that it is good to invest in the space. Dipan Mehta, Member at BSE & NSE told CNBC-TV18, “Typically when pharma companies come out with earnings, there is a fair degree of volatility and there are surprises negative as well ... Read More »

The Clever Sheep

The Clever Sheep Let us enjoy reading this one of Aesop’s Fables of The Clever Sheep. One day a wolf cornered a sheep. “You can’t escape,” said the wolf, baring his teeth. “I know,” said the sheep, softly. “Please grant me a last wish. Sing a song so that I may dance one last time.’ “Certainly,’ said the wolf and ... Read More »

Rs 2,277 drug can treat hepatitis B patients

Rs 2,277 drug can treat hepatitis B patients An effective drug for treating hepatitis B virus (HBV) could be mass-produced for as little as USD 36 per person per year against the current US price of over USD 15,000, scientists say. The advance could lead to huge reductions in the number of people being infected with Hepatitis B which causes ... Read More »

Sun Pharma plunges 11% as Daiichi Sankyo sells 8.9% stake

Sun Pharma plunges 11% as Daiichi Sankyo sells 8.9% stake Shares of  Sun Pharma  plunged 11 percent intraday on Tuesday after Daiichi Sankyo decided to offload its stake. Daiichi Sankyo has sold its its entire 8.9 percent stake via multiple blocks at between Rs 930-968 per share (lower end of the band). Daiichi has raised USD 3 billion via stake sale in Sun Pharma. Daiichi ... Read More »

Finding Solution in difficult situations

Finding Solution in difficult situations Good story with a nice message! A father left 17 Camels as an Asset for his Three Sons. When the Father passed away, his sons opened up the will. The Will of the Father stated that the Eldest son should get Half of 17 Camels, The Middle Son should be given 1/3rd of 17 Camels, ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes
Social Media Auto Publish Powered By : XYZScripts.com